AstraZeneca PLC (AZN)
NYSE: AZN · Real-Time Price · USD
188.01
-5.02 (-2.60%)
At close: Feb 9, 2026, 4:00 PM EST
189.00
+0.99 (0.53%)
After-hours: Feb 9, 2026, 7:59 PM EST

AstraZeneca Revenue

AstraZeneca had revenue of $15.19B in the quarter ending September 30, 2025, with 11.99% growth. This brings the company's revenue in the last twelve months to $58.13B, up 13.52% year-over-year. In the year 2024, AstraZeneca had annual revenue of $54.07B with 18.03% growth.

Revenue (ttm)
$58.13B
Revenue Growth
+13.52%
P/S Ratio
5.07
Revenue / Employee
$625,694
Employees
92,900
Market Cap
294.44B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202454.07B8.26B18.03%
Dec 31, 202345.81B1.46B3.29%
Dec 31, 202244.35B6.93B18.53%
Dec 31, 202137.42B10.80B40.58%
Dec 31, 202026.62B2.23B9.16%
Dec 31, 201924.38B2.29B10.38%
Dec 31, 201822.09B-375.00M-1.67%
Dec 31, 201722.47B-537.00M-2.33%
Dec 31, 201623.00B-1.71B-6.90%
Dec 31, 201524.71B-1.84B-6.93%
Dec 31, 201426.55B741.00M2.87%
Dec 31, 201325.81B-2.17B-7.75%
Dec 31, 201227.97B-5.62B-16.72%
Dec 31, 201133.59B322.00M0.97%
Dec 31, 201033.27B465.00M1.42%
Dec 31, 200932.80B1.20B3.81%
Dec 31, 200831.60B2.04B6.91%
Dec 31, 200729.56B3.08B11.65%
Dec 31, 200626.48B2.53B10.54%
Dec 31, 200523.95B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Johnson & Johnson94.19B
Merck & Co.65.01B
Pfizer62.58B
AbbVie61.16B
Novartis AG56.67B
Sanofi54.85B
Novo Nordisk48.59B
Bristol-Myers Squibb Company48.19B
Revenue Rankings